Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate Among Veterans with Schizophrenia-Reference-Cited by-同舟云学术

Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate Among Veterans with Schizophrenia

Published:2021-10 Issue: Volume:Volume 17 Page:3159-3170
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

El Khoury Antoine C,Patel Charmi,Mavros Panagiotis,Huang Ahong,Wang Li,Bashyal Richa

Publisher

Informa UK Limited

Reference39 articles.

1. Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US Veterans

2. Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate

3. Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics

4. American Psychiatric Association. What is schizophrenia?; July, 2017. Available from: https://www.psychiatry.org/patients-families/schizophrenia/what-is-schizophrenia. Accessed December 16, 2020.

5. National Institute of Mental Health. Schizophrenia; May, 2018. Available from: https://www.nimh.nih.gov/health/statistics/schizophrenia.shtml. Accessed December 16, 2020.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Retention Rates of 3-monthly Paliperidone Palmitate and Risk Factors Associated with Discontinuation: A Population-based Cohort Study;Clinical Psychopharmacology and Neuroscience;2023-08-31

2. How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients;Molecular Psychiatry;2023-07-21

3. Paliperidone–Cation Exchange Resin Complexes of Different Particle Sizes for Controlled Release;Pharmaceutics;2023-03-13